Ameriprise’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.73M	Buy	+180,851	New	+$1.73M	﹤0.01%	2997
2024 Q1	–	Sell	-82,244	Closed	-$751K	–	3937
2023 Q4	$751K	Buy	82,244 +70,842	+621%	+$647K	﹤0.01%	3302
2023 Q3	$118K	Buy	+11,402	New	+$118K	﹤0.01%	3780